Synergy Innovation Co., Ltd. (KOSDAQ:048870)
1,784.00
-38.00 (-2.09%)
At close: May 20, 2026
Synergy Innovation Company Description
Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea.
It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation – universal transport solutions (SI-UTS); and invests and develops in various fields comprising microorganism, bacteria, and virus.
The company also provides pharmaceutical formulations; and develops non-vascular stents. Synergy Innovation Co., Ltd. was founded in 1998 and is headquartered in Seongnam-Si, South Korea.
Synergy Innovation Co., Ltd.
| Country | South Korea |
| Founded | 1998 |
| CEO | Han-Ki Kim |
Contact Details
Address: 52, Sagimakgol-ro Seongnam-Si South Korea | |
| Phone | 82 3 1746 2560 |
Stock Details
| Ticker Symbol | 048870 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Han-Ki Kim | Chief Executive Officer |
| Gil Hwan Ahn | Chief Financial Officer |